https://www.thebodypro.com/category/hiv-treatment-strategies

HIV Treatment Strategies

The Latest

Sundararajan Team and TBA
Interviews

Traditional Healers Offer a Culturally Competent Approach to HIV Testing Gaps

In sub-Saharan Africa, herbalists and spiritual healers are working closely with researchers to help reduce HIV transmission in rural communities.

By Terri Wilder, M.S.W.
David Alain Wohl recaps CROI 2021 research during a video interview
Conference Coverage

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
clinical trial
Interviews

Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists

A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

By Terri Wilder, M.S.W.
antibodies
News

HIV Data Bites: Recent Advances in Broadly Neutralizing Antibodies for HIV Prevention

While findings from the high-profile AMP studies have excited scientists, they’re only one of a wide range of bNAb avenues currently being pursued.

By Michael Broder
injectable
News

Long-Acting ART Is Here. How Do We Make It Work for Our Patients?

Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

By Larry Buhl
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

Broadly Neutralizing Antibodies for HIV? If We Can Do It for COVID ...

David Alain Wohl, M.D., shares his thoughts on broadly neutralizing antibodies for COVID-19—and the extent to which we can hope to see similar developments in HIV.

By David Alain Wohl, M.D.
Hippocratic oath
News

This Week in HIV Research: U=U and the Hippocratic Oath

April 1, 2021: The ethics of teaching U=U; the role of primary care in HIV service acceptance; STI testing rates in transgender women; the potential in anal self-sampling.

By Barbara Jungwirth and Myles Helfand
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

CROI 2021 Takeaway: Long-Acting Antiretrovirals for HIV Treatment

David Alain Wohl, M.D., talks through new data regarding long-acting antiretroviral therapy for HIV—and touches on the uncertainties clinicians face in incorporating this new treatment method into their practice.

By David Alain Wohl, M.D.
The main entrance to Grady Health System in downtown Atlanta, Georgia
News

How Can Clinics Become Safer Places for Transgender Women to Access PrEP?

Researchers recommend PrEP programs be linked to a gender-affirming care clinic, to build trust and retain patients in care.

By Mathew Rodriguez
injection vials
News

Long-Acting HIV Treatment and PrEP Pipeline Update: So Many Formulations!

CROI 2021 featured new research on a host of long-acting antiretrovirals in development, including less-frequent treatment injections, a weekly pill for HIV treatment, injectable PrEP, vaginal PrEP rings, and PrEP implants.

By Larry Buhl